KaiFuMD

PubMed

• MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
  Chengfeng Bi, Yuhua Huang, Roshia Ali, Fang Wang, Xia Yang, Alyssa Bouska, Lu Xu, Xinbao Hao, Javeed Iqbal, Dennis D Weisenburger, Matthew A Lunning, Wing C Chan, Juli...> ;Haematologica. 2024 Mar 28
• Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North Am...
  Barr, P. M., Barr, P. M., Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Hongxia Cheng, Lynette Smith, Ji Yuan, Hina Naushad Qureishi, Brian K Link, Me...> ;Journal of Hematology & Oncology. 2023 Dec 16
• Initial and follow-up evaluations on cerebrospinal fluid involvement by hematologic malignancy.
  Momen, N., Tario, J., Fu, K., Qian, Y.> ;Journal of Hematopathology. 2023 Sep 1
• Correction: Initial and follow-up evaluations on cerebrospinal fluid involvement by hematologic malignancy.
  Momen, N., Tario, J., Fu, K., Qian, Y.> ;Journal of Hematopathology. 2023 Sep 1
• Multiparameter flow cytometry and ClonoSEQ correlation to evaluate precursor B-lymphoblastic leukemia measurable residual disease.
  Momen, N., Tario, J., Fu, K., Qian, Y.> ;Journal of Hematopathology. 2023 Jun 1
• 3 citations
  OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.
  Yaxiao Lu, Yang Li, Jingwei Yu, Shen Meng, Chengfeng Bi, Qingpei Guan, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, James Arm...> ;Clinical Immunology. 2023 Jun 1
• 3 citations
  Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis.
  Zhengyan Yang, Hongyun Xu, Yupo Yang, Chaoqun Duan, Pai Zhang, Yang Wang, Kai Fu, Yonghong Shen, Marvin Xuejun Xu> ;Breast Cancer Research and Treatment. 2023 Jan 1
• 4 citations
  Composite Classic Hodgkin Lymphoma and Follicular Lymphoma: A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature.
  Yuhua Huang, Shimin Hu, Daniel P Larson, Min Shi, Rong He, Bhavana J Dave, Timothy C Greiner, Kai Fu, Ellen D McPhail, Rhett P Ketterling, L Jeffrey Medeiros, Ji Yuan> ;The American Journal of Surgical Pathology. 2022 Jun 1
• 1 citations
  Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus.
  Alejandro A Gru, Megan S Lim, Ahmet Dogan, Steven M Horwitz, Jan Delabie, Kai Fu, Deniz Peker, Vishnu V B Reddy, Mina L Xu, Kiran Vij, Graham W Slack, Roberto N Mirand...> ;Archives of Pathology & Laboratory Medicine. 2023 Jan 1
• 5 citations
  High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis.
  Philippa Li, Ji Yuan, Fahad Shabbir Ahmed, Austin McHenry, Kai Fu, Guohua Yu, Hongxia Cheng, Mina L. Xu, David L. Rimm, Zenggang Pan> ;Frontiers in Oncology. 2021 Aug 30
• 4 citations
  The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
  Warda Ibrar, Weiwei Zhang, Jesse L. Cox, Allison M. Cushman-Vokoun, Kai Fu, Timothy C. Greiner, Ji Yuan> ;International Journal of Laboratory Hematology. 2021 Jul 16
• [Clinicopathological features of intravascular peripheral T-cell lymphoma].
  X Guan, Y C Yang, Y Qi, W C Gong, Xiaoying Xu, Yafei Wang, Yuhong Guo, Y Luo, Lin Sun, K Fu, Bin Meng> ;Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 2021 Jul 14
• [Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma].
  Xin Yang, Shu Chen, Y Qi, Xiaoying Xu, X Guan, Y C Yang, Yanxue Liu, Yuhong Guo, W C Gong, Y N Gao, Xianhuo Wang, Wenliang Li, L F Li, K Fu, H L Zhang, Bin Meng> ;Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 2021 Jun 14
• Atypical lymphoid hyperplasia of cervix with clonal IGH/IGK and BCL6 gene rearrangements.
  Katrina Lancaster-Shorts, James O. Armitage, Timothy Greiner, Kai Fu, Ji Yuan> ;Pathology. 2021 Jun 1
• 38 citations
  MAP-kinase and JAK-STAT pathways dysregulation in plasmablastic lymphoma
  Joan Enric Ramis-Zaldivar, Blanca Gonzalez-Farre, Alina Nicolae, Svetlana Pack, Guillem Clot, Ferran Nadeu, Anja Mottok, Heike Horn, Joo Y. Song, Kai Fu, George E. Wri...> ;Haematologica. 2021 May 6
• A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphoma.
  Cheng Wang, Pamela A. Althof, Chengfeng Bi, Weiwei Zhang, Alyssa Bouska, Tian Tian, Xuan Zhang, Nanxi Jiang, Guohua Yu, Hongxia Cheng, Javeed Iqbal, Julie M. Vose, Jen...> ;British Journal of Haematology. 2021 May 3
• 4 citations
  SET-NUP214 Fusion Gene Involved Early T-Cell Precursor Acute Lymphoblastic Leukemia in Adult with B Marker Expression.
  Xiaoying Xu, Qiongli Zhai, Hao Jin, Yong Yu, Dongmei Han, Huilai Zhang, Kai Fu, Bin Meng> ;International Journal of General Medicine. 2021 Feb 25
• Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma.
  Yi Ding, Andrew Campbell, Xuan Zhang, Kai Fu, Ji Yuan> ;Pathology. 2021 Feb 1
• Lineage Assignment in Acute Leukemia: A Challenging Case in a Pediatric Patient.
  Karine Turcotte, Stefanie Lowas, Sachit Patel, Deborah Perry, Catalina Amador, Samuel J. Pirruccello, Kai Fu> ;Journal of Pediatric Hematology/oncology. 2021 Jan 1
• 1 citations
  Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma.
  Yang Li, Yue Fei, Lu Liu, Zheng Song, Xiangrui Meng, Lihua Qiu, Lanfang Li, Zhengzi Qian, Shiyong Zhou, Xiubao Ren, Chengfeng Bi, Bin Meng, Huilai Zhang, Xianhuo Wang,...> ;Journal of Cancer. 2021 Jan 1
• 18 citations
  Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.
  Xuan Zhang, Chengfeng Bi, Ting Lu, Weiwei Zhang, Ting Yue, Cheng Wang, Tian Tian, Xiaoyan Zhang, Yuhua Huang, Matthew A. Lunning, Xinbao Hao, Lauren E. Brown, William ...> ;Leukemia. 2020 Jan 1
• 25 citations
  Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteris...
  Xianhuo Wang, Tingting Zhang, Zheng Song, L. Li, Xuhan Zhang, Jing Liu, Xianming Liu, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Lixia Feng, Ge Hu, Bin Meng, Qiongli Zhai,...> ;International Journal of Cancer. 2019 Sep 1
• 10 citations
  Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma.
  Wei Li, Chengfeng Bi, Yating Han, Tian Tian, Xianhuo Wang, Huijing Bao, Xiaoying Xu, Xuhan Zhang, Lu Liu, Weiwei Zhang, Hai Gao, Huaqing Wang, Huilai Zhang, Bin Meng, ...> ;Cancer Biology & Medicine. 2019 Aug 1
• 16 citations
  Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
  Xuhan Zhang, Lu Liu, Shiyong Zhou, Kuo Zhao, Zheng Song, Ge Hu, Tingting Zhang, Yang Li, Lihua Qiu, Lanfang Li, Zhengzi Qian, Bin Meng, Yi Pan, Xiubao Ren, Xianhuo Wan...> ;Hematological Oncology. 2019 May 30
• 49 citations
  BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
  Xiaohong Zhao, Yuan Ren, Matthew A. Lawlor, Bijal D. Shah, Paul M.C. Park, Tint Lwin, Xuefeng Wang, Kenian Liu, Michelle Wang, Jing Gao, Tao Li, Mousheng Xu, Ariosto S...> ;Cancer Cell. 2019 May 13
• Join now to see all